Gene · 1848
Papers2,747
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,747
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-145 as a Potential Biomarker and Therapeutic Target in Patients with Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 37373169 | PubTator, text mining | PubMed |
| New Approaches to Targeted Therapy in Melanoma. | Cancers (Basel) | 2023 | 37370834 | PubTator, text mining | PubMed |
| Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions. | Sci Rep | 2023 | 37369741 | PubTator, text mining | PubMed |
| Novel strategies to prevent and overcome relapse after allogeneic hematopoietic cell transplantation in acute lymphoblastic leukemia. | Front Immunol | 2023 | 37359547 | PubTator, text mining | PubMed |
Child Developmental MRI (CDM) project: protocol for a multi-centre, cross-sectional study on elucidating the pathophysiology of attention-deficit/hyperactivity disorder and autism spectrum disorder through a multi-dimensional approach. | BMJ Open | 2023 | 37355265 | PubTator, text mining | PubMed |
| Multi-Omic Analysis of CIC's Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic Fidelity. | Cancers (Basel) | 2023 | 37345142 | PubTator, text mining | PubMed |
| Conservative treatment of endometrial cancer in women of reproductive age (Review). | Mol Clin Oncol | 2023 | 37323245 | PubTator, text mining | PubMed |
| Nutritional requirements of human induced pluripotent stem cells. | Stem Cell Reports | 2023 | 37315525 | PubTator, text mining | PubMed |
| miR-101-5p suppresses trophoblast cell migration and invasion via modulating the DUSP6-ERK1/2 axis in preeclampsia. | J Assist Reprod Genet | 2023 | 37300650 | PubTator, text mining | PubMed |
| Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial Preservation? | Int J Mol Sci | 2023 | 37298731 | PubTator, text mining | PubMed |
| Mutation in the Common Docking Domain Affects MAP Kinase ERK2 Catalysis and Stability. | Cancers (Basel) | 2023 | 37296900 | PubTator, text mining | PubMed |
| LEM Domain Containing 1 Acts as a Novel Oncogene and Therapeutic Target for Triple-Negative Breast Cancer. | Cancers (Basel) | 2023 | 37296887 | PubTator, text mining | PubMed |
| Examining the relationship between birth weight and attention-deficit hyperactivity disorder diagnosis. | Front Psychiatry | 2023 | 37293403 | PubTator, text mining | PubMed |
| Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target. | Med Oncol | 2023 | 37291277 | PubTator, text mining | PubMed |
| Inflammation and aging: signaling pathways and intervention therapies. | Signal Transduct Target Ther | 2023 | 37291105 | PubTator, text mining | PubMed |
| Novel therapeutic targets to halt the progression of Parkinson's disease: an in-depth review on molecular signalling cascades. | 3 Biotech | 2023 | 37265542 | PubTator, text mining | PubMed |
| The role of m6A methylation in therapy resistance in cancer. | Mol Cancer | 2023 | 37264402 | PubTator, text mining | PubMed |
| Interaction of genetic liability for attention deficit hyperactivity disorder (ADHD) and perinatal inflammation contributes to ADHD symptoms in children. | Brain Behav Immun Health | 2023 | 37251547 | PubTator, text mining | PubMed |
| TRIM11 Posttranscriptionally Modulated by miR-5193 Facilitates Tumor Growth and Metastasis of Prostate Cancer. | Technol Cancer Res Treat | 2023 | 37248611 | PubTator, text mining | PubMed |
| Investigating Mammalian Formins with SMIFH2 Fifteen Years in: Novel Targets and Unexpected Biology. | Int J Mol Sci | 2023 | 37240404 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1848/papers?page=13